Scientific progress in the treatment of rare diseases is both an opportunity to improve lives and a financial challenge given the high cost of therapies. As stressed by the EU Commission, part of the […]

A lifelong promoter of vaccines suspects he might be the rare, unfortunate exception. On September 22 of last year, Michel Goldman, a Belgian immunologist and one of Europe’s best-known champions of medical research, walked […]

L’immunologiste Michel Goldman (ULB) cosigne un ouvrage sur les vaccins à destination d’un public non averti. Pédagogique mais jamais pédant, il vient en parler dans des classes de 6e primaire et du 1er degré du […]

In 2022, the National Academy of Technologies of France will host this event for which the theme is « Engineering a better world – Breakthrough Technologies for Healthcare ». It will be held […]

Together with Imperial College Business School, Università Bocconi, The London School of Economics and Political Science (LSE) and other business schools, […]

Alors que la progression du variant BA.5 et le nombre d’admissions à l’hôpital se confirment de jour à jour, le gouvernement fait preuve d’une inertie dommageable pour la protection des immunodéprimés qui ne répondent pas […]